During the past decade, Somers Cancer Research Building conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Somers Cancer Research Building" are "Lymphoma, Non-Hodgkin's" (1 trials) and "Peripheral T-cell Lymphoma" (1 trials). Many other conditions were trialed in "Somers Cancer Research Building" in a lesser frequency.

Most popular intervention types in "Somers Cancer Research Building" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Romidepsin" (1 trials) and "lenalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Somers Cancer Research Building" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Somers Cancer Research Building". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Somers Cancer Research Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Somers Cancer Research Building, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".